By Jessica Hamzelou The baby baboon is wearing a mesh gown and appears to be sitting upright. “This little lady … looks pretty philosophical, I would say,” says Eli Katz, who is showing me the image over a Zoom call. This baboon is the first to receive a heart transplant from a young gene-edited pig as part of a study that should pave the way for similar transplants in human babies, says Katz, chief medical officer at the biotech company
Related Posts
Why New Delhi needs to mount an India-driven global health-diplomacy push, and what it needs to do
Workers unload cartons of a Covid-19 coronavirus vaccine being delivered from India to Myanmar Synopsis The pandemic has catapulted India…
Mankind Pharma IPO: Mankind Pharma IPO: Reasonably priced, investors may join the company on its ‘Bharat-to-India’ quest
Rajeev Juneja, Vice Chairman & Managing Director at Mankind Pharma Ltd. image courtesy: company. Synopsis Adopting a contrarian strategy, Mankind…
Sun Pharma: Why Sun Pharma is shelling out USD576 million on a hair-loss drug to fire its specialty-drugs game
Sun Pharmaceutical Industries is scaling new heights. After a setback in the US generic-drugs business, India’s largest drugmaker has gradually…
